226 related articles for article (PubMed ID: 15279568)
1. A molecular understanding of mast cell activation and the promise of anti-allergic therapeutics.
Kovarova M; Rivera J
Curr Med Chem; 2004 Aug; 11(15):2083-91. PubMed ID: 15279568
[TBL] [Abstract][Full Text] [Related]
2. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
Gomez G
Front Immunol; 2019; 10():175. PubMed ID: 30792720
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Picture of Mast Cell Activation: The Complex Regulatory Network of High-Affinity Receptor for Immunoglobulin E Signaling.
Suzuki R
Biol Pharm Bull; 2017; 40(11):1828-1832. PubMed ID: 29093329
[TBL] [Abstract][Full Text] [Related]
4. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
[TBL] [Abstract][Full Text] [Related]
5. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
6. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
7. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
8. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
[TBL] [Abstract][Full Text] [Related]
9. Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation.
Uchida R; Egawa T; Fujita Y; Furuta K; Taguchi H; Tanaka S; Nishida K
Mol Immunol; 2019 Jan; 105():32-37. PubMed ID: 30472514
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.
Kraft S; Fleming T; Billingsley JM; Lin SY; Jouvin MH; Storz P; Kinet JP
J Exp Med; 2005 Feb; 201(3):385-96. PubMed ID: 15684326
[TBL] [Abstract][Full Text] [Related]
11. Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.
Furumoto Y; Gonzalez-Espinosa C; Gomez G; Kovarova M; Odom S; Parravicini V; Ryana JJ; Rivera J
Immunol Res; 2004; 30(2):241-53. PubMed ID: 15477664
[TBL] [Abstract][Full Text] [Related]
12. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.
Suurmond J; Dorjée AL; Knol EF; Huizinga TW; Toes RE
Clin Exp Allergy; 2015 Apr; 45(4):788-96. PubMed ID: 25665021
[TBL] [Abstract][Full Text] [Related]
13. Adapters in the organization of mast cell signaling.
Alvarez-Errico D; Lessmann E; Rivera J
Immunol Rev; 2009 Nov; 232(1):195-217. PubMed ID: 19909365
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE as a mast cell-stabilizing therapeutic agent.
Chang TW; Shiung YY
J Allergy Clin Immunol; 2006 Jun; 117(6):1203-12; quiz 1213. PubMed ID: 16750976
[TBL] [Abstract][Full Text] [Related]
15. Homoisoflavanone prevents mast cell activation and allergic responses by inhibition of Syk signaling pathway.
Lee YS; Hur S; Kim TY
Allergy; 2014 Apr; 69(4):453-62. PubMed ID: 24446972
[TBL] [Abstract][Full Text] [Related]
16. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond.
Dema B; Suzuki R; Rivera J
Int Arch Allergy Immunol; 2014; 164(4):271-9. PubMed ID: 25227903
[TBL] [Abstract][Full Text] [Related]
19. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
[TBL] [Abstract][Full Text] [Related]
20. Attainments in atop: special aspects of allergy and IgE.
Milgrom H
Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
